CN102379967A - Traditional Chinese medicine for treating diabetic retinopathy - Google Patents

Traditional Chinese medicine for treating diabetic retinopathy Download PDF

Info

Publication number
CN102379967A
CN102379967A CN2011102934657A CN201110293465A CN102379967A CN 102379967 A CN102379967 A CN 102379967A CN 2011102934657 A CN2011102934657 A CN 2011102934657A CN 201110293465 A CN201110293465 A CN 201110293465A CN 102379967 A CN102379967 A CN 102379967A
Authority
CN
China
Prior art keywords
chinese medicine
diabetic retinopathy
traditional chinese
parts
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011102934657A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2011102934657A priority Critical patent/CN102379967A/en
Publication of CN102379967A publication Critical patent/CN102379967A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a traditional Chinese medicine for treating diabetic retinopathy, which belongs to the field of the traditional Chinese medicine capable of treating diabetes; the traditional Chinese medicine for treating diabetes has the characteristics of good effect and fast effectiveness. The traditional Chinese medicine for treating diabetic retinopathy is composed of mulberry leaf, pseudoginseng, radix rehmanniae, ganoderma lucidum, Chinese angelica, equisetum and the like. The traditional Chinese medicine for treating diabetic retinopathy has the effects of strengthening the body resistance and archaeus, invigorating qi and nourishing blood, promoting blood circulation and removing blood stasis, and nourishing liver and improving eyesight, and has the advantages of remarkable effect, exact medicinal effect and quick effectiveness.

Description

A kind of Chinese medicine of treating diabetic retinopathy
Technical field
The invention belongs to the field of Chinese medicines of treatment diabetes.
Background technology
Diabetic retinopathy is one of diabetes common complication, is a treatment " difficult problem " of generally acknowledging both at home and abroad at present.The existing Chinese medicine that is intended to treat diabetic retinopathy; Exist some obviously not enough: the one, effect is humbleer; The 2nd, it is slower to take effect; Blurred vision, retina microangioma, retinal hemorrhage, edema especially not effective means and the channel of western medicine and medical practitioners to alleviating this disease formation so that large quantities of diabetic retinopathy conditions of patients constantly develops, worsens, can only " lose one's sight " at last in addition.Patient and family members thereof are very dissatisfied to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating diabetic retinopathy, and it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect; The slower problem that takes effect, effective, instant effect, it is remarkable to have effect; Drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating diabetic retinopathy adopts the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Folium Mori 3---18 parts of 9 portions of Radix Notoginseng 1---3 portions of Radix Rehmanniae 6---
Ganoderma 6---6 parts of 18 parts of Radix Angelicae Sinensis 6---18 parts of Herba Equiseties Hiemalis 2---
The Chinese medicine of this treatment diabetic retinopathy is processed by following method:
(1) by above-mentioned weight ratio, Folium Mori, Radix Rehmanniae, Ganoderma, Radix Angelicae Sinensis, Herba Equiseti Hiemalis are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1) extract fine powder.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think that diabetic retinopathy is the microangiopathies of diabetic retina in essence at research; Its main diseases is because of being the diabetics hypoimmunity, deficiency of both QI and YIN, and the five internal organs are scorching; The blood network stasis of blood stagnates; Blood coagulates, gathers, sticks, and causes blood supply insufficiency, with the passing of time causes amphiblestroid injury.Control and to attach most importance to supplementing QI and nourishing YIN heat clearing away, blood circulation promoting and blood stasis dispelling to set upright.The maximum characteristics of we are to start with from enhancing immunity, and through " removing " and " reparation " effect of immunity, blood clean makes blood no longer sticky, but rich mobile, the retina blood supply is full.This is the key of treatment primary disease.The maximum value of the present invention just is: do not have at present under the situation that active drug can control in this disease; It can save thousands of diabetic retinopathy patients' vision, realizes two targets: the one, and the microangiopathies of remarkable relieving retina makes it no longer to develop and worsen; Eyes " do not lose one's sight "; The 2nd, the microangiopathies of repairing retina makes it " reverse " takes place, and makes the whole or big portion of impaired vision obtain " recovery ".We can say that this is a comparatively great invention.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling, eliminating stasis to stop pain; Be aided with Folium Mori, Herba Equiseti Hiemalis's wind-dispelling heat-dissipating, nourishing the liver to improve visual acuity, relieving inflammation to remove nebula.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of nourishing the liver to improve visual acuity, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Folium Mori 300 gram Radix Notoginseng 100 gram Radix Rehmanniae 600 grams
Ganoderma 600 gram Radix Angelicae Sinensis 600 gram Herba Equiseties Hiemalis 200 grams
Press predetermined weight, Folium Mori, Radix Rehmanniae, Ganoderma, Radix Angelicae Sinensis, Herba Equiseti Hiemalis are extracted, process extract fine powder 230 grams with conventional water extraction process; Radix Notoginseng is ground into fine powder, mixes, stir with said extracted thing fine powder; Process fine particle; The capsule of packing into No. 0 is processed 1178 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.3 gram.
2, get following prescription (weight is unit by gram):
Folium Mori 600 gram Radix Notoginseng 180 gram Radix Rehmanniae 1200 grams
Ganoderma 1200 gram Radix Angelicae Sinensis 1200 gram Herba Equiseties Hiemalis 400 grams
By above-mentioned same method, process 2133 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
3, get following prescription (weight is unit by gram):
Folium Mori 900 gram Radix Notoginseng 300 gram Radix Rehmanniae 1800 grams
Ganoderma 1800 gram Radix Angelicae Sinensis 1800 gram Herba Equiseties Hiemalis 600 grams
By above-mentioned same method, process 3300 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
4, get following prescription (by weight):
8 parts of 1 portion of Radix Rehmanniae of 4 portions of Radix Notoginseng of Folium Mori
3 parts of 8 parts of Herba Equiseties Hiemalis of 8 parts of Radix Angelicae Sinensis of Ganoderma
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
5, get following prescription (by weight):
17 parts of 3 portions of Radix Rehmanniae of 8 portions of Radix Notoginseng of Folium Mori
5 parts of 17 parts of Herba Equiseties Hiemalis of 17 parts of Radix Angelicae Sinensis of Ganoderma
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic retinopathy, through 26 routine clinical observations.Selecting the tcm diagnosis diabetic retinopathy is standard: visual deterioration, blurring of vision; Microangioma appears in retina, is the fluorescence point during fluoroscopic visualization; White macula, macula lutea, blood stain appear in retina; The flocculence white macula appears in retina; New vessels appears in retina, causes retinal hemorrhage, vitreous hemorrhage.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 15 examples, women's 11 examples do not have other serious disease, and the age is 39 years old-78 years old, 60.5 years old mean age.
Efficacy determination:
1, produce effects: eyes are clear and bright, vision restoration, and vision improves more than 0.1; Fluoroscopic visualization shows that retina microangioma disappears or basic the disappearance; Retina white macula, macula lutea, blood stain and flocculence white macula disappear basically; Big disappearance of retinal neovascularization, the vitreous hemorrhage basic absorption.
2, effective: retina microangioma reduces, and vitreous hemorrhage partially absorbs.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that the specific embodiment of the invention 2 is made, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.3 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.26 philtrums of clinical experiment, produce effects 14 people, effective 10 people, invalid 2 people, total effective rate 92.3%.

Claims (1)

1. Chinese medicine of treating diabetic retinopathy is characterized in that: said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Folium Mori 3---18 parts of 9 portions of Radix Notoginseng 1---3 portions of Radix Rehmanniae 6---
Ganoderma 6---6 parts of 18 parts of Radix Angelicae Sinensis 6---18 parts of Herba Equiseties Hiemalis 2---
The Chinese medicine of this treatment diabetic retinopathy is processed by following method:
(1) by above-mentioned weight ratio, Folium Mori, Radix Rehmanniae, Ganoderma, Radix Angelicae Sinensis, Herba Equiseti Hiemalis are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1) extract fine powder.
CN2011102934657A 2011-09-27 2011-09-27 Traditional Chinese medicine for treating diabetic retinopathy Pending CN102379967A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102934657A CN102379967A (en) 2011-09-27 2011-09-27 Traditional Chinese medicine for treating diabetic retinopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102934657A CN102379967A (en) 2011-09-27 2011-09-27 Traditional Chinese medicine for treating diabetic retinopathy

Publications (1)

Publication Number Publication Date
CN102379967A true CN102379967A (en) 2012-03-21

Family

ID=45820067

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102934657A Pending CN102379967A (en) 2011-09-27 2011-09-27 Traditional Chinese medicine for treating diabetic retinopathy

Country Status (1)

Country Link
CN (1) CN102379967A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614303A (en) * 2012-04-20 2012-08-01 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic retinopathy
CN102670836A (en) * 2012-06-07 2012-09-19 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for curing diabetic retinopathy
CN107668708A (en) * 2017-11-20 2018-02-09 李志业 A kind of composition for protect eyes and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101856430A (en) * 2009-04-08 2010-10-13 周艳 Green tonic lucid ganoderma (three immortals) cream for preventing sub-health and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101856430A (en) * 2009-04-08 2010-10-13 周艳 Green tonic lucid ganoderma (three immortals) cream for preventing sub-health and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614303A (en) * 2012-04-20 2012-08-01 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic retinopathy
CN102670836A (en) * 2012-06-07 2012-09-19 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for curing diabetic retinopathy
CN107668708A (en) * 2017-11-20 2018-02-09 李志业 A kind of composition for protect eyes and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102389488A (en) Traditional Chinese medicine for curing diabetic retinopathy
CN102379967A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102327379A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102389484A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102389485A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102389487A (en) Traditional Chinese medicine for curing diabetic retinopathy
CN101884693B (en) Traditional Chinese medicine for treating diabetic eye diseases
CN101966258A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102670827A (en) Chinese medicine for treating diabetic retinopathy
CN101843786A (en) Chinese medicament for treating diabetic eyeground pathological changes
CN102389495A (en) Traditional Chinese medicine for curing diabetic retinopathy
CN102114121A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101972343A (en) Traditional Chinese medicine for treating diabetic oculopathy
CN101940659A (en) Traditional Chinese medicine for treating diabetic eye disease
CN101953939A (en) Chinese medicament for treating diabetic eye diseases
CN101953938A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102614303A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN101843857B (en) Chinese medicament for treating diabetic eyeground pathological changes
CN102631533A (en) Traditional Chinese medicine (TCM) for treating diabetic retinopathy
CN102631460A (en) Traditional Chinese medicine (TCM) for treating diabetic retinopathy
CN102670836A (en) Traditional Chinese medicine for curing diabetic retinopathy
CN101843834B (en) Chinese medicament for treating diabetic eyeground pathological changes
CN101897809A (en) Traditional Chinese medicine for treating diabetic retinopathy
CN102018757A (en) Traditional Chinese medicine for treating eyeground pathological changes caused by diabetes
CN101843772A (en) Chinese medicament for treating diabetic oculopathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120321